Category Pharmaceutical Industry

North Dakota to Receive Nearly $3 Million in Whistleblower Lawsuit [Legal Monitor Worldwide]

Dec31

The state of North Dakota will be receiving nearly $3 million for its state Medicaid program as part of a whistleblower settlement between the federal government and a major pharmaceutical company.A Tuesday release from the North Dakota Department of Human Services announced that the state Medicaid program will receive about $2.99 million. The money comes […]

IGI Laboratories, Inc. Completes Its Sixth ANDA Filing For 2013 Under Joint Drug Development And Commercialization Agreement

Dec31

BUENA, N.J., Dec. 31, 2013 /PRNewswire/ IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced it executed a license, development, supply and marketing agreement with a large multi-national pharmaceutical company. In accordance with the confidentiality agreement in place, the name of the company remains undisclosed. The agreement designates […]

Transcept Pharmaceuticals Inc. Files SEC Form 8-K, Current Report (Dec. 17, 2013)

Dec30

By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Transcept Pharmaceuticals Inc. (Form 8-K) was posted on December 17, 2013.The SIC code for this company is 2834, Pharmaceutical Preparations.There were 3 documents filed with […]

Researchers Submit Patent Application, “Safety Device for a Pre-Filled Syringe and an Injection Device”, for Approval

Dec30

By a News Reporter-Staff News Editor at Pharma Business Week From Washington, D.C., NewsRx journalists report that a patent application by the inventors Roberts, Gareth (Wrexham, GB); Ekman, Matthew (Cheshire, GB), filed on December 30, 2011, was made available online on December 19, 2013 (see also Pharmaceutical Companies).The patent’s assignee is Sanofi-aventis Deutschland Gmbh.News editors […]

Progen Pharmaceuticals Ltd Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16] (Dec. 18, 2013)

Dec30

By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Progen Pharmaceuticals Ltd (Form 6-K) was posted on December 17, 2013.The SIC code for this company is 2833, Medicinal Chemicals and Botanical Products.There were 4 […]

ViaCyte Appoints Mark Foletta, former CFO of Amylin, to its Board of Directors

Dec30

By a News Reporter-Staff News Editor at Diabetes Week ViaCyte, Inc., a leading regenerative medicine company developing a transformative cell therapy for treatment of diabetes, announced that Mark G. Foletta has been appointed to its Board of Directors (see also ViaCyte).Mr. Foletta is a seasoned financial executive with over 30 years of corporate experience. He […]

Adamis Pharmaceuticals Corp. Files SEC Form CERTNAS, Certification By The National Association of Securities Dealers Automated Quotation Approving…

Dec30

Adamis Pharmaceuticals Corp. Files SEC Form CERTNAS, Certification By The National Association of Securities Dealers Automated Quotation Approving Securities For Listing (Dec. 12, 2013)By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Adamis Pharmaceuticals […]

“Needle Adapter” in Patent Application Approval Process

Dec30

By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors Dasbach, Uwe (Frankfurt am Main, DE); Hofmann, Verena (Frankfurt am Main, DE), filed on February 16, 2012, was made available online on December 19, 2013, according to news reporting originating from Washington, D.C., by NewsRx correspondents (see also Pharmaceutical […]

Avanir Pharmaceuticals, Inc. Files SEC Form PRE 14A, Other Preliminary Proxy Statements (Dec. 18, 2013)

Dec30

By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Avanir Pharmaceuticals, Inc. (Form PRE 14A) was posted on December 18, 2013.The SIC code for this company is 2834, Pharmaceutical Preparations.There were 3 documents filed […]

Sucampo Pharmaceuticals, Inc. Files SEC Form 8-K, Current Report (Dec. 17, 2013)

Dec30

By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Sucampo Pharmaceuticals, Inc. (Form 8-K) was posted on December 17, 2013.The SIC code for this company is 2834, Pharmaceutical Preparations.There were 11 documents filed with […]